Table 1. Demographic and clinical characteristics of schizophrenias and healthy comparison subjects.
| Characteristic | Healthy Comparison Subjects (N = 100) | Schizophrenia Patients (N = 91) | Analysis | ||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | t/χ2 | df | p | |
| Age(years) | 33.3 | 10.5 | 33.8 | 7.7 | t = -0.34 | 189 | 0.73 |
| Sex | M45 | F55 | M51 | F40 | χ2 = 2.32 | 1 | 0.13 |
| Duration of illness (months) | 120.1 | 90.7 | |||||
| PANSS positive score | 16.6 | 8.0 | |||||
| PANSS negative score | 20.0 | 8.4 | |||||
| Current antipsychotic dosage (chlorpromazine equivalents) (mg/d) | 447.4 | 338.8 | |||||
PANSS indicates Positive and Negative Syndrome Scale.